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Summary 46 
Staphylococcus epidermidis is an opportunistic biofilm-forming pathogen associated 47 
with neurosurgical device-related meningitis. Expression of the polysaccharide 48 
intercellular adhesin (PIA) on its  surface promotes S. epidermidis biofilm formation. 49 
Here we investigated the proinflammatory properties of PIA against primary and 50 
transformed human astrocytes. PIA induced IL-8 expression in a dose and/or time 51 
dependent manner from U373 MG cells and primary normal human astrocytes. This 52 
effect was inhibited by depletion of N-acetyl-β-D-glucosamine polymer from the PIA 53 
with Lycopersicon esculentum lectin or sodium meta periodate.  Expression of dominant 54 
negative versions of the TLR2 and TLR4 adaptor proteins MyD88 and Mal in U373 MG 55 
cells inhibited PIA-induced IL-8 production. Blocking IL-1 has no effect. PIA failed to 56 
induce IL-8 production from HEK293 cells stably expressing TLR4.  However, in U373 57 
MG cells which express TLR2, neutralization of TLR2 impaired PIA-induced IL-8 58 
production. In addition to IL-8, PIA also induced expression of other cytokines from 59 
U373 MG cells including IL-6 and MCP-1. These data implicate PIA as an important 60 
immunogenic component of the S. epidermidis biofilm that can regulate 61 
proinflammatory cytokine production from human astrocytes, in part, via TLR2.  62 
 63 
 64 
 65 
 66 
 67 
 68 
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Introduction 69 
 Many neurosurgical procedures require the insertion of medical devices such as 70 
external ventricular drains/devices (EVDs) or cerebrospinal fluid (CSF) shunts to relieve 71 
intracranial pressure (Key et al., 1995; Yogev et al., 2000). The use of such devices can 72 
be associated with infective complications most often as a result of microbial 73 
colonisation and the development of biofilm on the surface of the shunt or EVD. 74 
Coagulase-negative staphylococci (CoNS), particularly Staphylococcus epidermidis are 75 
frequently associated with indwelling medical device infections including neurosurgical 76 
shunts and EVDs (Diaz-Mitoma et al., 1987), and there is evidence demonstrating the 77 
involvement of biofilm (Diaz-Mitoma et al., 1987; Younger et al., 1987; Kockro et al., 78 
2000). 79 
 The formation of S. epidermidis biofilm on a device surface involves host and 80 
bacterial factors (Costerton et al., 1987; Mack et al., 1992).  One of the primary 81 
components is an extracellular mucoid polysaccharide, known as polysaccharide 82 
intercellular adhesin (PIA), which facilitates cell-cell adhesion and accumulation into a 83 
mature biofilm (Mack et al., 1992).  PIA is a homoglycan, composed of poly-β-(1→6)-84 
N-acetylglucosamine, partially O-succinylated and partially de-N-acetylated (Mack et 85 
al., 1996; Sadovskaya et al., 2005).  Its production is associated with carriage of the 86 
intercellular adhesion operon (ica) consisting of four biosynthetic protein encoding 87 
genes (icaADBC) (Heilmann et al., 1996; Gerke et al., 1998) and icaR, a negative 88 
regulator (Conlon et al., 2002). The poly-N-acetylglucosamine backbone of the polymer 89 
is neutral; some negative charges are present due to partial O-succinylation and the 90 
introduction of positive charges along the molecule is dependent on the deacetylating 91 
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activity of IcaB.  Deacetylation of PIA has been reported to be important for both 92 
biofilm formation and immune evasion (Vuong et al., 2004).  93 
A major component of the innate immune response is the Toll-like receptor 94 
(TLR) family, which are a group of transmembrane receptor proteins expressed on the 95 
surface of sentinel cells of the immune system and other cell types (Tosi, 2005).  In the 96 
central nervous system (CNS) TLRs are expressed on the surface of astrocytes, 97 
microglia, and cerebrovascular endothelial cells (CVEs) (Bailey et al., 2006; Lehnardt et 98 
al., 2006).  Microbial recognition by TLRs is based on their ability to recognise 99 
conserved microbial structures and their function is to coordinate an efficient pro-100 
inflammatory immune response. Both TLR2 and TLR4 can recognise a variety of 101 
conserved microbial agonists from both Gram-positive and –negative bacteria. The 102 
current dogma being that TLR2 and TLR4 recognise lipopeptides and LPS, respectively.  103 
The signalling cascade leading to NFκB activation, and the production of pro-104 
inflammatory cytokines, from these receptors occurs via the adaptor proteins Myd88 and 105 
Mal/TIRAP.   106 
TLR2 has an important functional role in the host response to staphylococcal 107 
infection.  Whilst it remains a matter for debate TLR2 has been reported to recognise 108 
staphylococcal peptidoglycan and lipoteichoic acids (LTA) (Fournier et al., 2005). In 109 
the CNS astrocytes are the most abundant cell type that assume a pro-inflammatory 110 
functional role. They express TLRs (Bailey et al., 2006; Lehnardt et al., 2006) and TLR-111 
associated signalling proteins (Bsibsi et al., 2002; Kielan et al., 2002; Bowman et al., 112 
2003; Carpentier et al., 2005). It has previously been demonstrated that astrocytes are 113 
capable of recognising peptidoglycan via TLR2, and that their stimulation with 114 
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Staphylococcus aureus cell-wall material induced IL-1β, TNF-α, MIP-1 and MCP-1 115 
production (Esen et al., 2004). More recently, TLR2 has also been found to be important 116 
in the regulation of acute stage brain abscess formation caused by S. aureus and in 117 
neurodegeneration induced by Group B Streptococci in microglia (Kielan et al., 2005; 118 
Lehnardt et al., 2006).  In addition to this, other stimulants such as lipopolysaccharide 119 
(LPS), a known TLR4 agonist and the TLR9 agonist uCpG DNA have been shown to 120 
induce cytokine production from astrocytes (Lee et al., 2004; Yoo et al., 2008).  121 
To date, little is known regarding the host response to S. epidermidis biofilm-122 
related infections, and whether TLR-signalling is involved.  In the context of device 123 
related infections, it has been previously demonstrated that the glycocalyx produced by 124 
CoNS can induce cytokine production from murine peritoneal macrophages (Stout et al., 125 
1994).  There is mounting evidence supporting the recognition of carbohydrates by 126 
TLRs and that these represent a unique group of TLR agonists with immunogenic 127 
properties that are charge dependent (Kalka-Moll et al., 2002; Wang et al., 2005).  128 
Considering this, we investigated the immunogenic properties of PIA in human 129 
astrocytes and the role of TLRs in these events.  130 
  131 
 132 
  133 
 134 
 135 
 136 
 137 
 138 
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Results 139 
PIA induces IL-8 production from human astrocytoma U373 MG cells  140 
PIA is a major component of the S. epidermidis biofilm. We investigated PIA’s 141 
immunogenicity against U373 MG astrocytoma cells. Dose response experiments (0.01-142 
100 µg/ml PIA) performed at 24 h determined 10 µg/ml as the optimum dose of PIA for 143 
induction of IL-8 (Figure 1A). IL-1β also induced IL-8 and was used as a positive 144 
control. Time course studies confirmed 24h to be the optimal period with no further 145 
increase evident in IL-8 levels at 48 h (data not shown). THP-1 monocytic cells were 146 
also tested for PIA responsiveness. Compared to control cells (61+/-20 pg/ml IL-8) PIA 147 
at 10 or 100 µg induced 1147+/-126 and 1814+/-171 pg/ml IL-8, respectively (P<0.05 148 
for both) 149 
 150 
Lipopeptides, teichoic acids and nucleic acids are not involved in PIA induction of IL-8 151 
in U373 MG cells 152 
PIA is composed of repeating N-acetylglucosamine units. Lectin from 153 
Lycopersicon esculentum specifically binds oligomers of N-acetylglucosamine and, as 154 
such, is a useful tool for determining the purity of PIA preparations.  In order to ensure 155 
that the PIA-induced IL-8 response from U373 MG cells was as a result of stimulation 156 
with PIA and not contaminating cell-wall material e.g. lipoteichoic acid (LTA), PIA was 157 
left untreated or treated with  Lycopersicon esculentum lectin (which should bind to and 158 
remove PIA) and then added to the cells.  Figure 1B shows that the removal of N-159 
acetylglucosamine polymer from the PIA preparations using lectin, caused a significant 160 
decrease in IL-8 production (P≤0.05) in comparison to cells that were stimulated with 161 
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lectin-untreated PIA. Stimulation of U373 MG cells with LTA led to induction of IL-8, 162 
however this response was unaffected by pretreatment with lectin, which does not bind 163 
LTA. Furthermore treatment of U373 MG cells with cell wall teichoic acid (CWTA) (0-164 
500 µg/ml) isolated from S. epidermidis RP62A led to no detectable increase in IL-8 165 
production (data not shown) indicating that CWTA is unlikely to be a contaminating 166 
immunogenic factor in the PIA preparations used here. Hydrogen peroxide can destroy 167 
the IL-8 inducing capacity of lipid-containing molecules without affecting PIA. Figure 168 
1C shows that following treatment with H2O2 (1%, 37°C for 4 hrs (Zahringer et al., 169 
2008)), PIA retains its ability to induce IL-8. The ability of sodium meta periodate-170 
treated PIA to induce IL8 activity was also tested. Degradation of PIA with sodium meta 171 
periodate should destroy its IL-8 inducing activity. Figure 1D shows that treatment of 172 
PIA with sodium meta periodate abolishes its IL-8-inducing capacity. 173 
Although we were unable to exclude the possibility of trace amounts of 174 
lipopeptides in our PIA preparations, from our GLC fatty acid analysis (Figure 1E) we 175 
calculated that no more than 0.005% (w/w) fatty acids could be present. This equates to 176 
0.05ng lipoprotein per 10 µg PIA. Stimulation of U373 MG cells with a dose of 177 
lipopeptide even 10-times higher (0.5 ng) failed to induce IL-8 expression (data not 178 
shown). The PIA contained no contaminating nucleic acids as measured by UV spectra 179 
or sugar analysis. 180 
 181 
Acetylation of PIA is important for its ability to induce IL-8 expression from U373 MG 182 
cells  183 
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 We next assessed the role of acetylation in the ability of PIA to induce IL-8 184 
production from U373 MG cells. As before stimulation of cells with PIA displaying 185 
~20% deacetylation, as measured by 1H-NMR analysis, resulted in a significant 186 
induction of IL-8 production (P= 0.0003), whereas PIA that was fully deacetylated 187 
failed to induce a response (Figure 1F).  188 
 189 
Induction of IL-8 from U373 MG cells by an adhered biofilm produced by ica- and ica+ 190 
S. epidermidis isolates 191 
 Next we investigated whether carriage of the ica operon led to increased IL-8 192 
production from U373 MG astocytoma cells by intact, adhered S. epidermidis biofilm 193 
(Figure 2). Compared to control cells, BM13, a PIA-producing ica+ isolate, but not 194 
BM3, an ica- isolate, significantly increased IL-8 production (Figure 2A) from U373 195 
MG cells. The IL-8 induction was similar to that stimulated with an adhered biofilm, 196 
formed by the strong biofilm- producing S. epidermidis strain RP62A. Figure 2B  shows 197 
the degree of biofilm produced on the glass surface following staining with crystal 198 
violet.  199 
 200 
∆Myd88 and ∆Mal, but not IL-1ra, inhibit PIA-induced IL-8 expression in U373 MG 201 
cells. 202 
We investigated the mechanism by which PIA induces IL-8 from U373 MG cells by 203 
focusing on the IL-1R/TLR family. Having ruled out the involvement of IL-1RI, by 204 
demonstrating that IL-1ra could not significantly inhibit PIA-induced IL-8 production 205 
whilst effectively blocking IL-1-induced IL-8 expression (Figure 3A), we then 206 
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determined the effect of ∆MyD88 on the PIA effect. Figure 3B shows that expression of 207 
a ∆MyD88 transgene significantly inhibits PIA-induced IL-8 expression. IL-1 was used 208 
as a positive control as ∆MyD88 is known to inhibit IL-1RI signaling (Muzio et al., 209 
1997). 210 
MyD88 is an adaptor protein for the IL-1R/TLR family. Mal is a homologue of 211 
MyD88 involved in TLR2 and TLR4 signaling. Figure 3C demonstrates that expression 212 
of a functionally inactive version of Mal (Mal P/H) significantly inhibited PIA-induced 213 
IL-8 production from U373MG cells. LPS- but not IL-1-induced IL-8 expression was 214 
also inhibited. The PIA response in Figure 3C is lower than in 3B due to differences in 215 
transfection efficiencies between the two experiments. 216 
We also evaluated the effect of CAY10470, an inhibitor of NFκB, on PIA-217 
induced IL-8 expression. Figure 3D shows that PIA-induced IL-8 is inhibited by 218 
CAY10470, further implicating an NFκB signaling cascade in this response. IL-1 was 219 
used as a control. 220 
 221 
PIA signals via TLR 2 to induce IL-8 production in U373 MG cells 222 
 To determine if PIA-induced IL-8 production was TLR4-dependent, we 223 
stimulated a stably transfected TLR4-only expressing HEKTLR4 cell line with PIA. In 224 
comparison to LPS treatment, which led to a significant increases in IL-8 protein 225 
production at  doses of 1 or 10 µg, PIA treatment of HEKTLR4 cells had no measurable 226 
effect on IL-8 (Figure 4A), suggesting that TLR2 rather than TLR4 may be the receptor 227 
mediating PIA’s effect in U373 MG cells. LPS at 1 and 10 µg maximally induced IL-8 228 
expression from HEKTLR4. 229 
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  To confirm the role of TLR2, we quantified the effect of TLR2 and TLR4 230 
neutralising antibodies on inhibition of PIA-induced IL-8 production in U373 MG cells. 231 
Figure 4B shows that inhibition of TLR2 decreased PIA-induced IL-8 production by 232 
~40% (P<0.05). An isotype control antibody was used as a control.  The TLR2 233 
neutralising antibody also blocked IL-8 production induced by LTA, a known TLR2 234 
agonist. The TLR4 neutralising antibody had no effect on the PIA response but did 235 
significantly decrease LPS-induced IL-8. 236 
 237 
U373 MG cells express TLR2 on the cell surface  238 
 Quantitative fluorescence microscopy was used to detect expression of TLR2 239 
and TLR4 on U373 MG cells. Figure 5A illustrates that these cells express detectable 240 
TLR2 on their surface. The median channel fluorescence (MCF) emitted by the FITC-241 
linked anti-TLR2 antibody is significantly greater than that of the isotype antibody (P< 242 
0.0011). Expression of TLR4 by these cells was considerably higher. This may explain 243 
in part the relatively small inhibition of the LPS response by the TLR4 neutralising 244 
antibody seen in Figure 4B.  245 
 246 
Primary human astrocytes express TLR2 and respond to PIA. 247 
Figure 5B shows that, similar to the transformed astrocytoma cells, primary 248 
normal human astrocytes also express cell surface exposed TLR2. Furthermore these 249 
cells produce detectable levels of IL-8 and respond to PIA stimulation in a dose-250 
dependent manner (Figure 5C). 251 
 252 
 12 
PIA regulates expression of multiple cytokines. 253 
The effect of stimulation of U373 MG cells with PIA on a range of cytokines was 254 
assessed by cytokine array analysis. PIA induced production of a number of cytokines 255 
(Figure 6A) and representative examples of those displaying the most obvious increases 256 
in production compared to unstimulated cells were selected for further study, namely IL-257 
8, IL-6 and MCP-1. The array findings were validated by performing cytokine-specific 258 
ELISAs on the same cell supernatants (Figure 6B). Finally levels of IL-8, IL-6 and 259 
MCP-1 were quantified in different CSF samples. Figure 6C shows that CSF isolated 260 
from an individual infected with S. epidermidis contained significantly increased levels 261 
of IL-8, IL-6 and MCP-1 compared to normal CSF or inflamed, sterile CSF. 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
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Discussion 271 
 Here we link PIA, a major component of the S. epidermidis biofilm, to activation 272 
of TLR2 and expression of IL-8 in human astrocytes.  273 
Biofilm formation is a primary virulence factor of S. epidermidis. The 274 
production of PIA and the subsequent formation of biofilm have an important role in 275 
protecting the bacteria from phagocytosis (Johnson et al., 1986; Falceri et al., 1987). 276 
Conversely staphylococcal glycocalyces, including that produced by S. epidermidis, 277 
have been reported to activate the innate immune response at doses of 10-100 µg/ml 278 
leading to production of prostaglandin E2 (PGE2), IL-1 and TNF-α in murine peritoneal 279 
macrophages (Stout et al., 1994).  This is in keeping with our finding that S. epidermidis 280 
PIA induces a potent IL-8 response from human astrocytes at similar doses and another 281 
recent report describing how a capsular polysaccharide from the Gram-negative 282 
Bacteroides fragilis can activate NFκB in a TLR2-dependent manner (Wang et al., 283 
2006).  284 
Myd88 belongs to a family of TLR adaptor proteins. Whilst MyD88 signals for 285 
all TLRs with the exception of TLR3, a second adaptor protein termed Mal/TIRAP 286 
(Fitzgerald et al., 2001) is involved only in TLR2 and TLR4 signaling (Horng et al., 287 
2001; Yamamoto et al., 2002). Human astrocytes express mRNA for both Myd88 and 288 
Mal/TIRAP (Farina et al., 2007).  By blocking signaling through these adaptor proteins, 289 
neutralizing TLR2 and 4 and studying the effect of PIA on TLR4-only expressing 290 
HEKTLR4 cells we confirmed the likely involvement of TLR2 in the PIA response.  291 
TLR2 has a role in the recognition of structural components of a variety of 292 
Gram-positive bacteria, such as S. epidermidis and S. aureus, as well as fungal and 293 
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protozoan structures (Kopp et al., 2003).  Kielan et al. (2005) have shown that TLR2 294 
recognises S. aureus peptidoglycan in a brain abscess model.  Furthermore, it was 295 
reported that TLR2 expression on astrocytes is necessary for the recognition of Gram-296 
positive peptidoglycan, and stimulation of these cells by cell wall material of S. aureus 297 
has been reported to result in the production of pro-inflammatory mediators (Esen et al., 298 
2004). Recently Zahringer et al. (2008) proposed that TLR2 is activated only by 299 
lipoproteins or lipopeptides, and that the activity of all other putative compounds so far 300 
reported as TLR2 agonists is due to contaminating lipopeptides/proteins. Having 301 
thoroughly determined the purity of our PIA preparations via NMR, fatty acid analysis 302 
and lectin, NaOH, H2O2 and sodium meta periodate inhibition studies we are confident 303 
that our observed effects represent a true phenomenon.   304 
TLR2 can signal as a heterodimer. In conjunction with TLR1 it confers 305 
responsiveness to LTA and triacylated lipopeptides whilst with TLR6 it can respond to 306 
diacylated MALP-2. In airway epithelial cells TLR2 and TLR5 are involved in the 307 
flagellin response (Soong et al., 2004), thus it is possible that TLR2 may signal co-308 
operatively with another TLR in response to PIA. TLR2’s role may not however, be via 309 
a direct interaction with PIA. In other cells types CD36 and RP105 act as co-receptors 310 
for TLR2 (Nagai et al., 2005, Triantafilou, 2006). 311 
We found that native PIA from S. epidermidis CIP 109562, displaying ~20% 312 
deacetylation (Sadovskaya et al., 2006) was capable of inducing a significant increase in 313 
IL-8 production.  However, PIA that was 100% deacetylated, failed to induce the same 314 
response.  The deacetylation of N-acetylglucosamine residues, through the activity of 315 
IcaB, introduces positive charges along the length of the molecule, and this appears to 316 
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be important in PIA-mediated biofilm formation and immune evasion (Heilmann et al., 317 
1996, Vuong et al., 2004).  Using a mouse model of device-related infection, it was 318 
shown that a S. epidermidis ∆icaB mutant was significantly impaired in its ability to 319 
establish infection compared to a wild type strain (Vuong et al., 2004). Kalka-Moll and 320 
co-workers (Kalka-Moll et al., 2002) reported that bacterial polysaccharides from B. 321 
fragilis, S. aureus, and S. pneumoniae with zwitterionic charge motifs represent an 322 
unusual group of carbohydrates with possibly unique immunogenic properties.  Since 323 
PIA can be considered as a zwitterionic polymer the immunogenic properties of this 324 
polysaccharide may also be charge dependent. Our observation that deacetylation of PIA 325 
with NaOH abolishes its IL-8 activating activity support this. 326 
Until recently, there has been much circumstantial evidence supporting TLR 327 
expression by astrocytes. This evidence has been based on the ability of known ligands, 328 
such as LPS, Gram-positive cell wall antigens and unmethylated CpG DNA to induce 329 
cytokine production from the astrocytes (Schumann et al., 1998; Chung et al., 1990; 330 
Takeshita et al., 2001).  Here we show that both LTA and LPS can induce IL-8 331 
production in U373 MG astrocytoma cells, and provide direct evidence for the presence 332 
of TLR2 on these cells. Moreover, we demonstrate the previously unreported expression 333 
of TLR2 in primary normal human astrocytes. Our observations support the work of 334 
Bowman et al (2003), who demonstrated constitutive, low level expression of mRNA-335 
encoding TLR2, as well as TLR4, TLR5, and TLR9 in cultured astrocytes and Lehnardt 336 
et al. (2006) who reported TLR2 expression by murine astrocytes. Others have reported 337 
that cultured human astrocytes display low basal level expression of TLR2, along with 338 
TLR3 and TLR4 (Bsibsi et al., 2002).  Although the IL-8 response induced by PIA in 339 
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the primary NHA cells was less potent than in the transformed cell line it is possible that 340 
other S. epidermidis factors are likely to enhance cytokine expression by astrocytes in 341 
vivo. Although S. epidermidis CWTA failed to induce IL-8 production from U373 MG 342 
cells, other biofilm mediators such as the cell wall proteins Aap (Rohde et al., 2005; 343 
Stevens et al. 2008), Bap/Bhp (Lasa et al., 2006) or AtlE (Heilmann et al., 1997), that 344 
were not present in our PIA preparations could potentially activate TLR2 or other TLRs 345 
in vivo. 346 
Stimulation of U373 MG cells with an intact S. epidermidis biofilm, adhered to a 347 
glass surface and produced by known meningitis-causing isolates with variant ica 348 
genotypes caused different degrees of IL-8 production. The only significant change 349 
however was with a known meningitis-causing S. epidermidis isolate with an ica+ 350 
genotype.  Whilst it is unlikely that the IL-8 production was solely the result of 351 
stimulation by PIA present in the biofilm, other cell wall antigens, such as LTA but not 352 
CWTA, and peptidoglycan may possibly have been involved.  It is therefore possible 353 
that other components of S. epidermidis biofilm may also contribute to biofilm-related 354 
meningitis in vivo.   355 
Our cytokine array analysis revealed that in addition to IL-8 production, PIA 356 
stimulation of astrocytes also led to increased production of other NFκB activated genes 357 
including IL-6 and MCP-1.  In vivo astrocytes produce IL-8, IL-6 and MCP-1 as well as 358 
other important mediators of astrocyte function, such as RANTES and IL-1β (Farina et 359 
al., 2007).  IL-6 has an important immunomodulatory role in the CNS in enhancing the 360 
initial local innate immune response.  Such activation can have profound effects in the 361 
BBB, increasing permeability and allowing for the translocation of peripheral 362 
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circulating immune cells into the CNS (Farina et al., 2007).  Production of IL-8 and 363 
MCP-1 by astrocytes is important in the attraction of immune cells into the CNS and 364 
MCP-1 in particular has been reported to have an important role in the recruitment of 365 
phagocytes in response to staphylococcal infections (Fournier et al., 2005). 366 
 Interestingly, IL-6, IL-8 and MCP-1 were also detected in CSF taken from a 367 
patient clinically diagnosed with active meningitis, resulting from S. epidermidis 368 
infection.  The S. epidermidis isolate responsible for this infection possessed the genetic 369 
determinants (icaADBC) necessary for PIA production and was capable of biofilm 370 
formation in vitro (data not shown).  All three cytokines were present at higher 371 
concentrations in the CSF from this patient, compared to patient CSF that displayed 372 
signs of inflammation due to non-infective causes, and a patient CSF that displayed no 373 
signs of inflammation or infection.  Additional studies using more patient samples may 374 
reveal a real association between the factors.  375 
It is now widely accepted that the primary strategy of S. epidermidis immune 376 
evasion involves production of a biofilm.  Although expression of PIA is necessary for 377 
protection against phagocytosis and killing by antibacterial peptides (Vuong et al., 2004; 378 
Schroder, 1999), we have demonstrated here that PIA also has pro-inflammatory 379 
immunogenic properties.  380 
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Experimental procedures  381 
Cell culture and treatments. U373 MG human astrocytoma cells were obtained from the 382 
European Collection of Cell Cultures (ECACC), primary normal human astrocytes 383 
(NHA) from Lonza, U.K. and HEKTLR4 cells from Invivogen.  U373 MG cells were 384 
cultured in Eagle’s Minimal Essential Medium (MEM) (GIBCO®) supplemented with 385 
10% FCS, 1% L-glutamine, 1% sodium-pyruvate, 1% non-essential amino acid 386 
(GIBCO®), and 1% penicillin/streptomycin (Invitrogen Life Sciences). NHA cells were 387 
cultured in the supplied astrocyte basal medium (Clonetics®, Lonza) supplemented with 388 
3% FCS, 0.3% ascorbic acid, 0.1% recombinant human EGF, 0.1% GA-1000, 0.25% 389 
Insulin, 1% L-glutamine (Clonetics®, Lonza), and 1% penicillin/streptomycin 390 
(Invitrogen Life Sciences). HEKTLR4 cells were cultured in Dulbecco’s Modified 391 
Eagle’s Medium (DMEM) (GIBCO®) supplemented with 10% FCS, 1% 392 
penicillin/streptomycin (Invitrogen Life Sciences), and 1% blastocidin (10 mg/ml) 393 
(Invivogen).  Twenty-four hours prior to agonist treatment, cells were placed under 394 
serum-free conditions or in media containing 1% FCS for LPS stimulations. Cells were 395 
maintained at 37 oC in a humidified atmosphere of 5% CO2. 396 
Agonist treatments were performed in serum-free conditions or 1% FCS 397 
conditions as appropriate. Unless otherwise stated, treatments were performed on 1 x 398 
105 cells per ml. 399 
 400 
Preparation of PIA and Cell Wall Teichoic Acid (CWTA). PIA was prepared from a 401 
crude extract of S. epidermidis 5 (CIP 109562), a strain from our collection as described 402 
previously by (Sadovskaya et al., 2005). Briefly, the bacteria were grown statically in 403 
750 ml TSB in 3-1 Erlemeyer flasks at 37oC for 24 h.  Bacterial biofilms on the bottom 404 
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of the flasks were washed twice with NaCl (0.9% w/v) and collected in 0.9% NaCl using 405 
6 mm diameter glass beads.  The suspension was then sonicated twice, 30 s each, on ice 406 
using an Ikasonic sonicator (IKA Labortechnik) set to 50% amplitude and 50% duty 407 
cycle.  The sonicate was clarified twice by centrifugation (2,000 x g, 4 oC, 15 min, then 408 
8,700 x g, 4 oC, 10 min).  Following this, the supernatant was concentrated using an 409 
Amicon 10 kDa cutoff ultrafiltration cell.  TCA was added to a concentration of 5% and 410 
the precipitate was removed by centrifugation (8,700 x g, 4 oC, 10 min).  The now 411 
protein-free extract was fractionated on a Sephacryl S-300 column (1 x 80 cm), eluted 412 
with water.  Amino sugar-rich fractions corresponding to HMW PIA were pooled and 413 
lyophilized. 414 
 The purity of the PIA was also examined by 1H-NMR (Varian UNITY INOVA 415 
500 instrument). CWTA was obtained from the SDS-treated S. epidermidis RP62A as 416 
described previously (Sadovskaya et al., 2004). 417 
 418 
Purity of PIA assay. The purity of the PIA was checked by 1H-NMR (Varian UNITY 419 
INOVA 500 instrument) and monosaccharide analysis, as described previously 420 
(Sadovskaya et al, 2005).  Glucosamine was the only monosaccharide present in the PIA 421 
preparation. In order to exclude the possible contamination with LTA, S. epidermidis 422 
LTA and the PIA preparation were analysed for the presence of fatty acids as fatty acids 423 
methyl ester (FAME) by gas liquid chromatography (GLC). LTA of S. epidermidis 424 
RP62A was prepared from defatted cells as described in (Iwasaki et al., 1986). The 425 
purified S. epidermidis LTA (0.5 mg) was heated in 2 M HCl in absolute methanol at 85 426 
°C for 6 h. The reaction mixture was evaporated to dryness under a stream of nitrogen, 427 
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the residue dissolved in 250 µl of chloroform and analysed by GLC on Shimadzu GC-14 428 
gas chromatograph equipped with a flame ionization detector and a Zebron ZB-5 429 
capillary column (30 m x 0.25 mm), with hydrogen as carrier gas using a temperature 430 
gradient 170 °C (3 min), 260 °C at 5°C/min. 5 mg of PIA preparation were treated 431 
similarly, and the residue was taken in 10 µl of chloroform. No peaks corresponding to 432 
fatty acids were detected in the PIA preparation (Fig 1E).  433 
UV spectra of the PIA preparation and GlcNAc standard (50 µg/ml) were 434 
detected using a Helios b spectrophotometer in the range of 200-300 nm.   435 
 Lycopersicon esculentum Lectin (1 mg/ml) (Sigma) binds N-acetyl-β-D-436 
glucosamine oligomers and was used to determine the purity of the PIA preparations. 437 
Fifty µg lectin was incubated in a 1:1 ratio with PIA (1 mg/ml) or LTA (1 mg/ml) at 25 438 
oC for 1 h and centrifuged at 14,000 rpm for 30 min. Supernatants were removed and 439 
used to stimulate the U373 MG astrocytoma cells. 440 
 For fatty acid analysis, 5 mg of PIA preparation were heated in 2 M HCl in 441 
absolute methanol at 85 °C for 6 h. The reaction mixture was evaporated to dryness 442 
under a stream of nitrogen, the residue dissolved in 10 µl of chloroform and analysed by 443 
gas liquid chromatography on Shimadzu GC-14 gas chromatograph equipped with a 444 
flame ionization detector and a Zebron ZB-5 capillary column (30 m x 0.25 mm), with 445 
hydrogen as carrier gas using a temperature gradient 170 °C (3 min), 260 °C at 5°C/min. 446 
Purified S. epidermidis LTA (0.5 mg) was treated similarly as a standard. No peaks 447 
corresponding to fatty acids were detected in the PIA preparation. 448 
 449 
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Cytokine protein production. Cells were left untreated or stimulated with agonists or 450 
vehicle controls, as indicated.  In some experiments cells were pretreated with IL-1R 451 
antagonist (IL-1ra, 0.1 µg/ml) (R & D Systems), or a TLR2 neutralising antibody 452 
TLR2.1 (25 µg/ml) (Bioquote Ltd), or IgG2a (25 µg/ml) (Bioquote Ltd) for 1 h before 453 
agonist treatment. 454 
IL-8, IL-6, and MCP-1 protein concentrations in cell supernatants and patient 455 
CSF specimens were determined by sandwich ELISA (R & D Systems).  Assays were 456 
performed at least three times and in duplicate or triplicate on each occasion. 457 
The expression of 174 different cytokines and growth factors in cell supernatants 458 
from untreated and PIA treated U373 MG astrocytoma cells was detected using the 459 
RayBio® Human Cytokine Antibody Array C series 2000 kit (RayBiotech Inc.), 460 
according to the manufacturer’s instructions.  Signals were detected following exposure 461 
to X-ray film (Kodak).  Densitometry readings were obtained through illumination on an 462 
ultraviolet source (LKB Bromma, 2011 macrovue Transilluminator) and recorded using 463 
a gel documentation system (Stratgene Eagle Eye® II). 464 
 465 
Collection of CSF specimens. CSF was collected from neurosurgical patients with an 466 
EVD in situ at Beaumont Hospital, Dublin, by healthcare professionals following 467 
informed consent and using the appropriate clinical criteria as approved by the hospital 468 
ethics committee, over a three year period as part of routine care.  CSF specimens were 469 
examined for sterility or for the presence of S. epidermidis, following growth on 470 
Columbia blood agar. S. epidermidis was identified using the API®20 Staph 471 
identification system (Biomerieux). CSF specimens were centrifuged at 1000 x g for 10 472 
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min and cell free supernatants were immediately transferred into a sterile tube and 473 
stored at – 80oC until required for experimental analysis.  CSF specimens were grouped 474 
into the three following defined categories; (i) inflammed CSF, where CSF was sterile 475 
and inflammation was due to non-infective cause (n = 1), (ii) normal CSF, where CSF 476 
was sterile with no evidence of inflammation as determined by the diagnostic 477 
laboratory, that is, normal glucose, protein, and white blood cell count levels (n = 9), 478 
and (iii) inflammed and infected CSF, where CSF showed evidence of inflammation, 479 
resulting from infection with S. epidermidis (n = 1). 480 
 481 
Transfection and reporter gene studies. Transfections were performed according to the 482 
methods described previously (Greene et al., 2005). Transfections were performed into 483 
cells using TransFast Reagent (Promega) in a 1:1 ratio, according to the manufacturer’s 484 
instructions, using 100 ng of NF-κB5-linked luciferase reporter plasmid and 200 ng of 485 
either pCDNA3.1 (Invitrogen Life Technologies) or ∆MyD88 expression plasmid 486 
(Greene et al., 2005) or pDC304 or Mal P/H expression vector (Carroll et al., 2005). 487 
∆MyD88 contains only a functional TIR domain and lacks the death domain required 488 
for downstream signaling.  MalP/H is a dominant-negative version of Mal that has a 489 
Pro125His point mutation in box 2 of the TIR domain.  Cells were supplemented with 490 
additional growth media for 24 h at 37 oC before being left unstimulated or stimulated as 491 
indicated.  Cells were lysed with reporter lysis buffer (Promega), and reporter gene 492 
activity was quantified by luminometry (PerkinElmer Wallac Victor2, 1420 multilabel 493 
counter) using the Promega luciferase assay system, according to the manufacturer’s 494 
instructions. 495 
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 496 
Laser-scanning cytometry. U373 MG astrocytoma cells and NHA cells were seeded (1 x 497 
105 cells/well) in four well chamber slides (Nunc, UK), in duplicate.  Slides were fixed 498 
in methanol (AnalaR) for 5 min, and then labeled indirectly with goat-anti TLR 2 (Santa 499 
Cruz Biotechnology, USA) and anti-goat FITC, then counter-stained with propidium 500 
iodide (Molecular probes, USA), washed twice in PBS + 1% Tween and allowed to dry.  501 
Fluorescence excitation was provided by a 488 nm laser line.  Nuclear (PI) and TLR2 502 
(FITC) fluorescence were measured at 588 +/- 10 nm or 530 +/- 20 nm, respectively.  503 
Antibody-staining cells were then identified and quantified using CompuCyte software 504 
on the basis of integrated green fluorescence (Kamentsky et al., 1997). 505 
 506 
Data and Statistical analysis. Data was analyzed using GraphPad Prism 4.0 software 507 
package (GraphPad).  Data obtained from cytokine array analysis was analyzed using 508 
the Ray®Bio Analysis Tool (Ray®Biotech Inc.)  Results are expressed as mean ± SD, 509 
and were compared by One-tailed student t-test.  Differences were considered 510 
significant when the P value was ≤ 0.05. 511 
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Figure Legends 745 
Fig. 1. PIA induces IL-8 production from U373 MG astrocytoma cells.  746 
U373 MG astrocytoma cells (1 x 105/ml) were left unstimulated or stimulated with (A) 747 
vehicle, IL-1 (10 ng/ml) or PIA as indicated for 24 h, (B) PIA or LTA (10 µg/ml, 24 h) 748 
with or without prior treatment with lectin, (C) PIA or H2O2-treated PIA (10 µg/ml, 24 749 
h), (D) PIA or NaIO4-treated PIA (10 µg/ml, 24 h) and production of IL-8 was 750 
quantified in cell supernatants by ELISA. (E) GLC chromatographic profiles of FAME 751 
derived from PIA preparation (a, 50 µg/µl) and S. epidermidis LTA (b, 2 µg/µl). 752 
Assignments of FAME was made tentatively using different standards (SupelcoTM 37 753 
component FAME mix; olive oil FAME). (F) IL-8 ELISA of supernatants from PIA (10 754 
µg/ml), dPIA (10 µg/ml), or IL-1 (10 ng/ml) treated cells (24h). (* vs untreated cells).   755 
 756 
Fig. 2. IL-8 induction from U373 MG cells by S. epidermidis biofilm.   757 
(A) ∆IL-8 expression (pg/ml) from U373 MG astrocytoma cells (1 x 106 cells/ml) 758 
following stimulation fro 24 h with an adhered biofilm on a glass surface, formed by ica- 759 
(BM3) or ica+ (BM13) S. epidermidis isolates. The known ica+ biofilm-positive RP62A 760 
was included as a positive control. (B) Adherent biofilm on the glass surface was stained 761 
with crystal violet (0.4% w/v).  A glass slip with no adhered biofilm acted as a control. 762 
 763 
Fig. 3 MyD88, Mal and NFκB, but not IL-1, are involved in PIA-induced IL-8 764 
expression. 765 
U373 MG astrocytoma cells (1 x 105 cells/ml) (A) were left unstimulated or stimulated 766 
with PIA (10 µg/ml) or IL-1 (10 ng/ml) for 24 h with or without prior treatment with IL-767 
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1ra (how much?).  IL-8 production was quantified in cell supernatants by ELISA. (* vs. 768 
untreated cells, or # vs. agonist), or were cotransfected for 24 h with pRLSV40 (a 769 
constitutive luciferase reporter gene) plus (B) an empty vector (pCDNA3) or ∆Myd88 770 
expression plasmid or (C) an empty vector (pDC304) or Mal P/H expression plasmid 771 
then left untreated or stimulated with PIA (10 µg/ml), IL-1 (10 ng/ml) or LPS (10 772 
µg/ml) as indicated for 24 h. IL-8 levels were corrected for transfection efficiency and 773 
expressed in pg/ light unit (L.U.), or (D) PIA (10 µg/ml) or IL-1 (10 ng/ml) with or 774 
without prior treatment with CAY10470 (how much? How long?) (* vs. untreated cells, 775 
or # vs. agonist). 776 
 777 
Fig. 4. TLR2, not TLR4, mediates the PIA response in U373 MG cells. 778 
(A) HEKTLR4 cells (1 x 105 cells/ml) were stimulated with PIA (10 or 100 µg/ml) or 779 
LPS (1 or 10 µg/ml) fro 24 h and production of IL-8 was quantified in cell supernatants 780 
by ELISA. (* vs. untreated cells, or # vs. agonist). (B) U373 MG cells (1 x 105 cells/ml) 781 
were left untreated or stimulated with PIA (10 µg/ml), LTA (10 µg/ml) or LPS (10 782 
µg/ml) +/- IgG2a control isotype antibody, TLR2.1 or TLR4 neutralising antibodies (25 783 
µg/ml) for 1 h as indicated. Production of IL-8 was quantified in cell supernatants by 784 
ELISA. (* vs. untreated cells, or # vs. agonist).     785 
 786 
Fig. 5. Primary and transformed human astrocytes express TLR2 and respond to 787 
PIA. 788 
(A) U373 MG or (B) primary human NHA astrocytes (1 x 105/ml) were grown in 789 
chamber slides, Fc blocked, and labelled with FITC-conjugated anti-TLR2, anti-TLR4 790 
 36 
or an isotype control Ab. Cells were counterstained with PI and TLR surface expression 791 
was quantified by laser-scanning microscopy. Graphs show median channel 792 
fluorescence +/-SEM (* vs. isotype, n=6). (B) Inset shows representative histogram of 793 
FITC fluorescence comparing isotype- (clear) and anti-TLR2 Ab (solid)-labelled 794 
samples. (C) NHA cells (1 x 105 cells/ml) were left untreated or stimulated with PIA (10 795 
or 100 µg/ml) for 48 h. ELISA was used to quantify levels of IL-8 in cell supernatants 796 
(* vs untreated cells).     797 
 798 
Fig. 6. PIA induces the expression of cytokines associated with S. epidermidis 799 
meningitis. 800 
(A) U373 MG astrocytoma cells (1 x 105 cells/ml) were left untreated or stimulated with 801 
PIA (10 µg/ml) for 24 h. Cytokine array analysis was performed on pooled supernatants 802 
from triplicate samples and increases in the production of selected cytokines are 803 
depicted in densitometry units. IL-8, IL-6 and MCP-1 concentrations in (B) the same 804 
samples (* vs untreated cells) or (C) different categories of CSF were measured by 805 
ELISA (* vs normal CSF).  806 
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